
%20(2).jpg)

The Sage Group

WHO WE ARE
The Sage Group is a team of seasoned executives dedicated to serving healthcare industry across the USA, Europe, Australia, China, Japan, India, the Middle East, and Asia.
With over 30 years of experience, we specialize in strategic and transactional advice for healthcare and life science companies in pharmaceuticals, diagnostics, medical devices, regenerative medicine, biotechnology, bioscience.
Our focus is on partnering through and M&A, where we excel in identifying optimal partners, showcasing your assets, fostering competitive environments, assessing, and successfully negotiating transactions.
We turn your ambitions into tangible results.
OUR SERVICES
We provide a range of highly focused services for our global clients in healthcare and life sciences including:
-
Buyside and Sellside Licensing for Products and Technologies
-
Mergers, Aquisitions, Asset and IP Divestments
-
Aquisition Searches and Buy to Build
-
Sourcing of Non-Dilutive Financing from Strategic Partners
-
Business Development, Corporate Partnering
-
Through affiliates, we offer pricing and market access assessments in the US and Europe
-
Through affiliates, we offer regulatory advice and guidance in the US, Europe and APAC
-
Value Modelling

SECTORS OF EXPERTISE
Our clients are our most important assets. Sage corporate clients include Pharmaceutical and Biotechnology Companies in virtually every sector of healthcare:
-
Cardiology and Cardio-Metabolic
-
Dermatology
-
Endocrinology
-
Hematology
-
Immunology
-
Infectious Diseases
-
Metabolic Diseases
-
Nephrology and Hepatology
-
Neurology, CNS and Mental Health
-
Oncology
-
Ophthalmology
-
Pediatric Diseases
-
Rare Disease
-
Respiratory Diseases
-
Urology
-
Virology
-
Women's Healthcare
Involving the following technologies
-
AI
-
Cell therapy
-
Gene therapy
-
Immunology and Molecular Biology
-
Regenerative medicine
-
Drug Delivery
-
Drug Discovery
-
In-vitro Diagnostics and Laboratory Service
-
Medical Devices
In addition, we work closely with Venture Capital and Private Equity Investors, Financial Institutions and Banks















